The respiratory system moves air through the conducting airways, from the trachea and bronchi to the terminal bronchioles, where no gas exchange occurs. Gas exchange takes place across the thin alveolar-capillary membrane in the respiratory zone, where oxygen diffuses into the blood and carbon dioxide diffuses out. Ventilation depends on the diaphragm and intercostal muscles changing thoracic volume, creating pressure gradients that move air. Surfactant reduces surface tension in alveoli, preventing collapse. Matching of ventilation and perfusion across the lungs is essential, because mismatch causes hypoxemia even when total ventilation appears adequate. Understanding these foundations helps clinicians interpret symptoms, imaging and blood gas results in patients with respiratory disease.
2
Clinical respiratory terminology
What do common pulmonary terms such as dyspnea, hypoxemia, hypercapnia and wheeze mean in clinical practice?
Dyspnea is the subjective sensation of breathlessness, which clinicians describe using validated scales rather than relying on observation alone. Hypoxemia means reduced oxygen content in arterial blood, usually defined by a low partial pressure of oxygen or oxygen saturation, while hypercapnia means elevated arterial carbon dioxide, indicating inadequate ventilation. Wheeze is a continuous, high-pitched sound produced by narrowed airways, often associated with asthma or chronic obstructive pulmonary disease. Stridor is a harsher, inspiratory sound suggesting upper airway obstruction and may signal an emergency. Precise terminology allows teams to communicate findings accurately, document progress and compare results across clinicians and settings, reducing the risk of misinterpretation during handovers and referrals.
A focused respiratory history begins with the presenting complaint, including onset, duration, pattern and triggers of breathlessness, cough, sputum or chest pain. Clinicians should ask about smoking exposure in pack-years, occupational and environmental exposures, travel, family history of lung disease, medication use, allergies and prior hospital admissions. Sleep-related symptoms, exercise tolerance and effects on daily activity are also important, as is the impact on quality of life. Asking about recent infections, weight change and symptoms of heart failure helps distinguish respiratory from cardiac causes. A structured approach reduces omissions and provides the context needed to interpret examination findings, spirometry and imaging accurately in realistic clinical settings.
Spirometry measures the volume of air a patient can exhale forcefully, typically reporting forced vital capacity and forced expiratory volume in one second. An obstructive pattern is suggested when the ratio of forced expiratory volume in one second to forced vital capacity falls below the expected threshold, reflecting airflow limitation as seen in asthma or chronic obstructive pulmonary disease. A restrictive pattern shows reduced lung volumes with a preserved or normal ratio, consistent with conditions such as interstitial lung disease or chest wall abnormalities. Results must be interpreted against age, sex, height and ethnicity reference values, and quality criteria for technique must be met. Bronchodilator responsiveness testing can further characterize reversibility, guiding diagnosis and treatment decisions.
Chest radiography is usually the first imaging test, offering a rapid, low-cost overview of lung fields, heart size, pleura, bones and large airways. It can reveal consolidation, effusion, pneumothorax, masses and hyperinflation, but has limited sensitivity for small nodules and interstitial change. Computed tomography provides detailed cross-sectional images that characterize nodules, bronchiectasis, emphysema, interstitial patterns and mediastinal disease. High-resolution techniques target fine parenchymal detail, while contrast studies assess vascular abnormalities such as pulmonary embolism. Imaging decisions weigh diagnostic yield against radiation exposure and cost. Radiology reports must be correlated with clinical findings, and final interpretation rests with trained clinicians rather than images alone.
Asthma control is assessed by reviewing symptom frequency, night-time awakenings, reliever use, activity limitation and exacerbations over a recent period. Clinicians use validated questionnaires and objective measures such as peak expiratory flow or spirometry to quantify control. Severity is interpreted in light of treatment already being received, since well-controlled patients may appear mild while still needing therapy. Stepwise management in current guidelines generally begins with as-needed low-dose inhaled corticosteroid combined with a rapid-acting bronchodilator, escalating or stepping down according to response. Regular review, inhaler technique checks and adherence support are essential, because poor technique is a common cause of apparent treatment failure.
Management of stable chronic obstructive pulmonary disease focuses on smoking cessation, inhaled bronchodilators selected according to symptoms and exacerbation risk, vaccination against influenza and pneumococcus, and pulmonary rehabilitation. Pulmonary rehabilitation combines supervised exercise, education and psychological support, and is one of the most effective interventions for improving breathlessness and quality of life. Long-term oxygen therapy is indicated for patients with severe chronic hypoxemia, using criteria defined in guidelines. Action plans help patients recognize and respond to deterioration early. Regular review of symptoms, inhaler technique and comorbidities such as heart disease helps optimize outcomes. Care should be individualized, since treatment intensity differs considerably between patients with similar spirometry results.
Clinicians assess pneumonia severity using validated tools that combine clinical features, such as confusion, respiratory rate, blood pressure, age and urea, with oxygen saturation and sometimes arterial blood gases. These scores help estimate short-term mortality risk and guide whether treatment can safely occur at home or requires hospital admission. Clinical judgment remains essential, because scores do not capture social circumstances, frailty or the trajectory of illness. Chest imaging confirms the diagnosis, while microbiological sampling is targeted to severity and local resistance patterns. Early antibiotic therapy in line with national guidance, supported by appropriate oxygen and fluid management, is central to safe care, and decisions must be documented clearly for handover.
Acute respiratory failure is recognized by signs of respiratory distress, including increased work of breathing, use of accessory muscles, altered consciousness, cyanosis and tachypnea, combined with abnormal gas exchange. Arterial blood gas analysis is used to distinguish hypoxemic failure, with low partial pressure of oxygen, from hypercapnic failure, with rising carbon dioxide and acidosis. Pulse oximetry provides continuous monitoring but must be interpreted alongside clinical observation, since it can be affected by poor perfusion or pigmentation. Recognizing the pattern informs whether supplemental oxygen, non-invasive ventilation or intubation is needed. Escalation should follow local protocols, and repeated reassessment is essential because patients can deteriorate rapidly.
Non-invasive ventilation delivers positive pressure through a mask, supporting ventilation without an endotracheal tube and reducing the need for intubation in selected patients. It is commonly used in acute hypercapnic respiratory failure, for example in severe exacerbations of chronic obstructive pulmonary disease, and in cardiogenic pulmonary edema. Safe use requires an alert patient able to protect the airway, adequate facial anatomy for mask fit, stable hemodynamics and clinicians experienced in settings and monitoring. Contraindications include inability to tolerate the mask, vomiting, copious secretions and severe encephalopathy. Continuous reassessment of gas exchange and comfort determines whether the approach is working or whether invasive ventilation should be considered.
Infection prevention for suspected airborne respiratory infection includes early identification, placement of the patient in a single room with appropriate ventilation, and use of personal protective equipment matched to the pathogen and local policy. Staff should apply hand hygiene before and after patient contact and wear respirators when performing aerosol-generating procedures such as bronchoscopy, nebulization or non-invasive ventilation. Visitors and transport staff should follow the same principles, and patients should be encouraged to use respiratory hygiene and cough etiquette. Exact requirements vary with the suspected organism and national guidance, so teams should consult current infection prevention policy. Good documentation of isolation status supports safe handovers across departments.
Ventilator-associated pneumonia is a serious hospital-acquired infection, and prevention bundles combine several evidence-based measures. Head-of-bed elevation, typically around thirty degrees unless contraindicated, reduces aspiration of gastric contents. Daily sedation interruption and spontaneous breathing trials shorten ventilation duration, lowering exposure. Oral care with appropriate antiseptic regimens, careful management of endotracheal tube cuff pressure and subglottic secretion drainage where available help limit colonization. Hand hygiene and closed suction systems reduce cross-transmission. Teams should audit compliance with the bundle, since prevention depends on consistent daily practice. Local surveillance data help identify trends and guide improvement initiatives across intensive care units.
Clinical guidelines summarize available evidence and provide graded recommendations on diagnosis, treatment and monitoring for conditions such as asthma, chronic obstructive pulmonary disease and pneumonia. Clinicians use them as a framework rather than a rigid rulebook, weighing recommendations against the patient's comorbidities, preferences, drug interactions, resource constraints and local resistance patterns. Guidelines are periodically updated, so practitioners should check the currency of the version they follow. Strength of recommendation and quality of underlying evidence are important when deciding whether to depart from standard pathways. Documenting the reasoning behind significant deviations supports transparency, clinical governance and continuity of care within multidisciplinary teams.
Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep despite ongoing respiratory effort, causing snoring, breathing pauses and arousals. Central sleep apnea arises from reduced or absent respiratory drive from the brain, with no effort during pauses. The distinction matters because treatments differ: positive airway pressure is first-line for obstructive disease, while central apnea may require evaluation for heart failure, opioid use, neurological conditions or high-altitude exposure, and may need specialized ventilatory support. Misclassification can lead to inappropriate therapy. Sleep study interpretation therefore requires careful attention to the pattern of events, not only the overall number of events per hour.
Polysomnography records brain activity, eye movements, muscle tone, airflow, respiratory effort, oxygen saturation, heart rhythm and leg movements during sleep, allowing staging of sleep and detection of breathing events. Home sleep apnea testing uses a simplified set of sensors and is suitable for uncomplicated suspected obstructive sleep apnea in adults without major comorbidities. In-laboratory testing is preferred when there are suspected central or non-respiratory sleep disorders, significant heart or lung disease, opioid use, parasomnias, or when home testing has been technically inadequate. The choice balances diagnostic accuracy, patient safety, access and cost. Results must be interpreted by qualified clinicians in the context of symptoms and clinical history.
Continuous positive airway pressure delivers a constant air pressure through a mask, acting as a pneumatic splint that keeps the upper airway open during sleep. It effectively reduces breathing events, snoring and daytime sleepiness in many patients with moderate to severe obstructive sleep apnea. Adherence depends on mask fit, comfort, pressure settings, humidification, mouth leak and the patient's understanding of the benefits. Clinicians often assess adherence through device download data and follow-up appointments, addressing problems early. Non-adherence is common and is frequently linked to discomfort or poor expectation setting, so education and support are central to successful long-term therapy.
Sleep study recordings, device usage data and clinical notes contain sensitive health information that must be protected under applicable data protection law and professional confidentiality standards. Access should be limited to staff with a legitimate clinical need, and data should be transmitted and stored using secure systems. Patients should be informed about how their information will be used, including for remote monitoring or research, and their consent or legal basis for sharing must be documented. Telehealth and cloud-based device platforms require particular attention to security and vendor agreements. Breaches can cause harm and loss of trust, so services should maintain clear policies, staff training and incident reporting procedures.
A clear respiratory note should record the presenting problem, relevant history, examination findings, investigation results with dates, assessment, and the reasoning behind the plan. Medications should be listed with doses, changes and rationale, and oxygen requirements, inhaler technique assessment and any escalation decisions should be explicit. Follow-up arrangements, safety-netting advice and named responsible clinicians help receiving teams act appropriately. Documentation should be objective, avoid unexplained abbreviations and distinguish facts from interpretation. In many settings, copying letters to patients is also recommended, which promotes transparency. Good records protect patients, support audit and provide reliable evidence if clinical decisions are later reviewed.
Communicating serious diagnoses requires preparation, a quiet setting and an understanding of what the patient already knows. Clinicians should use plain language, avoid excessive jargon, check understanding by asking the patient to summarize key points, and allow time for emotional responses. Honesty about uncertainty and prognosis, delivered with sensitivity to the patient's preferences about information, supports trust. Offering written information, involving family members with the patient's permission and arranging specialist nurse or psychological support helps patients manage the news. Structured communication frameworks can guide consultations, and follow-up conversations often need to revisit topics as patients absorb the information.
Valid informed consent requires that patients receive information about the purpose of the procedure, its expected benefits, material risks, reasonable alternatives including no intervention, and what the procedure involves. For bronchoscopy, this includes sedation, the possibility of bleeding, pneumothorax with some biopsies, and the implications of findings. Pleural procedures carry risks such as bleeding, infection and pneumothorax, which should be discussed in proportion to likelihood and severity. Patients must have capacity to consent, be free from undue pressure, and have an opportunity to ask questions. Consent is recorded according to local policy, and it remains ongoing so that the patient can withdraw before the procedure.